Download pdf
The interplay between aging and inflammation and its role in chronic disease development
- 1 Nanjing University of Technology
* Author to whom correspondence should be addressed.
Abstract
This paper explores the complex relationship between aging and inflammation and its impact on the development of chronic diseases. Aging is an important contributor to elevated levels of inflammation, with mechanisms including changes in immune regulatory function, chronic low-grade inflammation, cellular aging and tissue damage, changes in gene expression, and increased oxidative stress. These inflammatory processes not only accelerate aging itself, but also promote the development of chronic diseases such as cardiovascular disease (CVD) and Alzheimer’s disease (AD). The article goes on to address other modern anti-inflammatory treatment approaches, such as biologics, JAK inhibitors, and nonsteroidal anti-inflammatory medications. These treatments help manage and mitigate aging-related pathologies by targeting key molecules and pathways of inflammation. A better comprehension of the relationship between inflammation and aging may serve as the foundation for the creation of novel therapeutic approaches that, in addition to reducing inflammatory reactions, may also prevent or slow the advancement of illnesses associated with age. This article aims to improve medical and scientific understanding of the relationship between inflammation and aging and to encourage the development and use of more potent therapies to lessen the burden of chronic illnesses and enhance the quality of life for the aged.
Keywords
Cardiovascular disease, Alzheimer’s disease, aging, inflammation
[1]. García-García V A Alameda J P Page A & Casanova M L 2021 Role of NF-κB in ageing and age-related diseases: lessons from genetically modified mouse models Cells 10 8 1906
[2]. Frasca D & Blomberg B B 2009 Effects of aging on B cell function Curr Opin Immunol 21 4 425-430
[3]. Pawelec G Goldeck D & Derhovanessian E 2014 Inflammation ageing and chronic disease Curr Opin Immunol 29 23-28
[4]. Zhou R Yazdi A S Menu P & Tschopp J 2011 A role for mitochondria in NLRP3 inflammasome activation Nature 469 7329 221-225
[5]. Lawrence T 2009 The nuclear factor NF-κB pathway in inflammation Cold Spring Harb Perspect Biol 1 6 a001651
[6]. Coppé J P Desprez P Y Krtolica A & Campisi J 2010 The senescence-associated secretory phenotype: the dark side of tumor suppression Annu Rev Pathol 5 99-118
[7]. Lu P Takai K Weaver V M & Werb Z 2011 Extracellular matrix degradation and remodeling in development and disease Cold Spring Harb Perspect Biol 3 12 a005058
[8]. Rubinsztein D C Mariño G & Kroemer G 2011 Autophagy and aging Cell 146 5 682-695
[9]. Feser J & Tyler J 2011 Chromatin structure as a mediator of aging FEBS Lett 585 13 2041-2048
[10]. Olivieri F Rippo M R Monsurrò V Salvioli S Capri M Procopio A D & Franceschi C 2013 MicroRNAs linking inflamm-aging cellular senescence and cancer Ageing Res Rev 12 4 1056-1068
[11]. López-Otín C Blasco M A Partridge L Serrano M & Kroemer G 2013 The hallmarks of aging Cell 153 6 1194-1217
[12]. Sies H Berndt C & Jones D P 2017 Oxidative stress Annu Rev Biochem 86 715-748
[13]. Libby P Ridker P M Hansson G K & Leducq Transatlantic Network on Atherothrombosis 2009 Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 23 2129-2138
[14]. Heneka M T Carson M J El Khoury J Landreth G E Brosseron F Feinstein D L & Kummer M P 2015 Neuroinflammation in Alzheimer’s disease Lancet Neurol 14 4 388-405
[15]. Zlokovic B V 2011 Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders Nat Rev Neurosci 12 12 723-738
[16]. Conner J M Franks K M Titterness A K Russell K Merrill D A Christie B R & Tuszynski M H 2009 NGF is essential for hippocampal plasticity and learning J Neurosci 29 35 10883-10889
[17]. O’Shea J J & Plenge R 2012 JAK and STAT signaling molecules in immunoregulation and immune-mediated disease Immunity 36 4 542-550
[18]. Schwartz D M Kanno Y Villarino A Ward M Gadina M & O’Shea J J 2017 JAK inhibition as a therapeutic strategy for immune and inflammatory diseases Nat Rev Drug Discov 16 12 843-862
[19]. Fleischmann R Kremer J Cush J Schulze-Koops H Connell C A Bradley J D & Kanik K S 2012 Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis N Engl J Med 367 6 495-507
Cite this article
Guan,J. (2024). The interplay between aging and inflammation and its role in chronic disease development. Theoretical and Natural Science,48,45-54.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Environmental Geoscience and Earth Ecology
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).